Peter sullivan is a reporter withthe hell, and the hill. What is the Biotechnology Innovation Organization . Trade we are the national a Photo Association for about 1000 biotech companies, most in the Drug Discovery business. When you think of pharma with a capital p, they are the biggest companies, mercks, pfizer merck, pfizer, Johnson Johnson. What distinguishes us is we have hundreds of Startup Companies that are on the cutting edge of biotechnology innovation of new medicines. drug pricing is the hot issue. Thatve seen polling data about three in 10 americans are basically rationing medicine because they cant afford it. Does that indicate a problem here, the drug prices are too high . Problem. Is a it is not necessarily a problem of drug pricing. It is a problem of Insurance Coverage and the way insurers Insurance Products are designed. When we talk about drug pricing unaffordability, there are two moral principles. The first moral imperative applies to all the people for whom we h
China allows further tarifffree soybeans aheads. Of highlevel negotiations in washington next week. And we see a united front in europe. Joining the United States in blaming iran for last weeks audi attack. President trump is set to deliver his address to the General Assembly today. Morning. Welcome to the european open. The u. S. 10 screen year yield over the past three days. 1. 7 . It trading at watch out for another selloff in treasuries that would spike the yield higher. Remember, we saw on friday the , friday a up to 1. 9 week ago. Take a look at the futures this morning as well. Have gains across the screen. Even dax futures are up 0. 2 . Are going to get numbers in just about an hour and a half from now. Pmik disappointment in yesterday. Investors may be bracing themselves. Nonetheless, buying futures on the dax index. Mark cudmore, Bloomberg Markets life editor markets a live editor. Germany is heading towards recession. Brings, butisk it it is a major drag on the Global Econom
Adaptation. Imate bill gates wants to help invest nearly 2 trillion to help the world become more resilient. His thoughts on and dental solutions for Climate Change potential solutions for Climate Change. Wework was the roadshow that wasnt. Of the most anticipated debuts of the year is postponed until october. Theyre looking for time to calm investor doubts about its dropping valuation, governance problems and financials. Point, this was supposed to be a 47 billion company. That number is now 15 billion and could be even smaller. Joining me to discuss this was the cofounder and chief revenue en,icer at equity is an z a marketplace for preipo shares. Lot to address before they can go out to the investors and ask them for their they were looking for 47 billion and now we are hearing it could be as low as 12 billion to 15 billion. They have made a lot of changes to corporate governance, but investors are looking at valuations, whether they will improve financials, and whether more is need
Host this week on newsmakers, former republican congressman James Greenwood from pennsylvania, served from 1993 to and currently is president 2005 and ceo of the Biotechnology Innovation Organization. We also have Peter Sullivan, reporter with the hill. And sarah carlon smith. Welcome to you all. Congressman, what is your organization, the Biotechnology Innovation Organization . James we are the National Trade association for about 1000 biotechnology companies. Most of them in the Drug Discovery business. When you think of pharma, they have the Biggest Companies in the industry merck, pfizer, Johnson Johnson. We have most of them as well, but one of the things that this thing wishes us, we have literally hundreds and hundreds of small Startup Companies on the cutting edge of biotechnology innovation of new medicines. Peter drug pricing is the hot issue. I will start with a general question. We have seen polling data that about 3 in 10 americans are basically rationing medicine because
So please welcome, first of all, and to think theyre coming in from the side, dr. Jenny colombo, the Vice President global patients and Scientific Affairs at takeda pharmaceuticals. Michele oshman, the director, federal advocacy and Alliance Development at eli lilly. Dr. Gwen nichols, the chief medical officer at the leukemia and lymphoma society. Doctor erin oshea, president of the Howard Hughes medical institute. Doctor peggy hamburg, the foreign secretary of the National Academy of medicine and former commissioner of the fda. And doctor janine clayton, director of the nih office of research on womens health. Our moderator this morning is lucinda maine, ceo of the American Association of colleges of pharmacy, and the pride to say boardmember of research america. Thank you all leaders. We look forward to this. My thanks really to organizers of the forum this year for giving us an opportunity to talk about some things we dont talk about so much, and we have an exemplary panel that brin